Name | PI-103 |
Synonyms | PI-103 PI-103HydrochlorideSalt PI 3-Kinase Inhibitor (PI-103) B-0303 3-[4-(4-Morpholinylpyrido[3',2',4,5]furo[3,2-d]pyrimidin-2-yl]phenol |
CAS | 371935-74-9 |
Molecular Formula | C19H16N4O3 |
Molar Mass | 348.36 |
Density | 1.409±0.06 g/cm3(Predicted) |
Solubility | Soluble in DMSO (up to 40 mg/ml) |
Appearance | White solid |
Color | White |
pKa | 9.06±0.10(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months. |
Use | PI-103 is a multi-target PI3K inhibitor, which has the best inhibitory effect on p110α, IC50 is 2 nM (slightly weaker inhibitory effect on p110β/δ/γ), mTORC1/2 and DNA-PK ,IC50 is 20 nM/83 nM and 8 nM respectively. |
In vitro study | PI-103 potently inhibits the apamycin-sensitive (mTORC1) and rapamycin-insensitive (mTORC2) complexes of the protein kinase mTOR. PI-103 is the third most targeted PI3K inhibitor. PI-103 Inhibits Constitutive and growth factor-induced activation of PI3K/Akt and mTORC1. In blast cells, particularly leukemic stem cells, PI-103 inhibits leukemic cell proliferation and colony formation of leukemic precursor cells, and induces mitochondrial apoptosis. PI-103 inhibits p110α more than 200-fold more than p110β. PI-103 also potently inhibits PI(3,4)P2 and PIP3 in adipocytes, and PIP3 in myotubes. Compared with The IC50 value of LY294002 inhibiting Akt phosphorylation, the IC50 value of PI-103 inhibiting Akt phosphorylation was 100 times lower. The PI-103 protects the animals from insulin-stimulated lowering of blood glucose. The combination of PI-103 and etoposide has the effect of enhancing apoptosis in blast cells and immature leukemia cells. |
In vivo study | When the tumor reaches 50-100mm |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.871 ml | 14.353 ml | 28.706 ml |
5 mM | 0.574 ml | 2.871 ml | 5.741 ml |
10 mM | 0.287 ml | 1.435 ml | 2.871 ml |
5 mM | 0.057 ml | 0.287 ml | 0.574 ml |
biological activity | PI-103 is a multi-target PI3K inhibitor, which has the best inhibitory effect on p110α, the IC50 is 2 nM (slightly less inhibitory effect on p110β/δ/γ) and also inhibits mTORC1/2 and DNA-PK, with IC50 of 20 nM/83 nM and 8 nM, respectively. PI-103 is a multi-target PI3K inhibitor, the IC50 for p110α/β/δ/γ in cell-free assay was 2 nM/3 nM/3 nM/15 nM, and the effect on mTOR/DNA-PK was small, the IC50 was 30 nM/23 nM. PI-103 can induce apoptosis of T cell lymphoma in mice. |
characteristics | PI-103 was the first potent synthetic mTOR inhibitor. |
Target | Value |
p110α (Cell-free assay) | 2 nM |
p110β (Cell-free assay) | 3 nM |
p110δ (Cell-free assay) | 3 nM |
p110γ (Cell-free assay) | 15 nM |
DNA-PK (Cell-free assay) | 23 nM |